EurekaMag
+ Translate
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19


Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19



European Journal of Pharmacology 885: 173496



ISSN/ISBN: 0014-2999

PMID: 32841640

DOI: 10.1016/j.ejphar.2020.173496

The rapid breakout of the coronavirus disease of 2019 (COVID-19) has been declared pandemic with serious global concern due to high morbidity and mortality. As we enter the phase beyond limitations there is an urgent need for explicit treatment against COVID-19. To face this immediate global challenge, drug development from scratch is a lengthy process and unrealistic to conquer this battle. Drug repurposing is an emerging and practical approach where existing drugs, safe for humans, are redeployed to fight this harder to treat disease. A number of multi clinical studies have repurposed combined cocktail (remdesivir + chloroquine and favipiravir + chloroquine) to be effective against COVID-19. However, the exact mechanistic aspect has not yet been revealed. In the present study, we have tried to decipher the mechanistic aspects of existing medicines at the viral entry and replication stage via the structural viroinformatics approach. Here we implied the molecular docking and dynamic simulations with emphasis on the unique structural properties of host receptor angiotensin-converting enzyme 2 (ACE2), SARS-CoV2 spike protein and RNA dependent RNA polymerase enzyme (RdRp) of the SARS-CoV2. Deep structural analysis of target molecules exposed key binding residues and structural twists involved in binding with important pharmacophore features of existing drugs [(7-chloro-N-[5-(diethylamino)pentan-2-yl]quinolin-4-amine (chloroquine),N-[[4-(4-methylpiperazin-1-yl)phenyl]methyl]-1,2-oxazole-5-carboxamide N-[[4-(4-methylpiperazin-1-yl)phenyl]methyl]-1,2-oxazole-5-carboxamide) (SSAA09E2), 2-ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-{4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl}-5-cyano-3 (remdesivir) and 6-Fluor-3-oxo-3,4-dihydro-2-pyrazincarboxamid (favipiravir)]. It is evident from this structural informatics study that combo of chloroquine + SSAA09E2 with remdesivir or favipiravir could significantly restrain the virus at the entry and replication stage. Thus, drug repurposition is an attractive approach with reduced time and cost to treat COVID-19, we don't have enough time as the whole world is lockdown and we are in urgent need of an obvious therapeutics' measures.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 072865876

Download citation: RISBibTeXText

Related references

Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach. Journal of Biomolecular Structure and Dynamics 2020: 1-13, 2020

Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials. Mini Reviews in Medicinal Chemistry 21(9): 1123-1143, 2021

Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected with COVID-19: a Systematic Scoping Review. Frontiers in Pharmacology 11: 585331, 2020

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system. Microbial Pathogenesis 168: 105608, 2022

Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay. Proceedings of the National Academy of Sciences of the United States of America 118(30), 2021

Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data. Therapeutic Advances in Drug Safety 12: 20420986211041277, 2021

Repurposed Gi Drugs in the Treatment of COVID-19. Digestive Diseases and Sciences 65(8): 2452-2453, 2020

Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach. Jmir Medical Informatics 8(11): E21648, 2020

Repurposed Drugs Against COVID-19: Safety Concerns and Stockout. Hospital Pharmacy 55(4): 218-219, 2020

Old Drugs for a new Virus: Repurposed Approaches for Combating COVID-19. Acs Infectious Diseases 6(9): 2304-2318, 2020

Impact of repurposed drugs on the symptomatic COVID-19 patients. Journal of Infection and Public Health 14(1): 24-38, 2021

Brief review on repurposed drugs and vaccines for possible treatment of COVID-19. European Journal of Pharmacology 898: 173977, 2021

Remdesivir and its Combination with Repurposed Drugs as COVID-19 Therapeutics. Frontiers in Immunology 13: 830990, 2022

Efficacy of repurposed antiviral drugs: Lessons from COVID-19. Drug Discovery Today 27(7): 1954-1960, 2022

Study Aims to Identify Drugs that could be Repurposed for COVID-19. JAMA 324(20): 2019, 2020